In this lecture, Speakers will discuss the use of monoclonal antibodies for migraine prevention reaching beyond reducing Migraine Headache days to improving the quality of life for Migraine patients.
After participating in the activity, Health Care Providers are expected to be better able to:
Understand where to place Monoclonal Antibodies in Migraine algorithm.
Understand which patients Monoclonal Antibodies may be prescribed and how to assess the response.
Understand the efficacy, safety and tolerability of Anti-CGRPs in clinical trials.
Prof. Antonio Russo (MD, PhD) is Associate Professor of Neurology working at the University of Campania “Luigi Vanvitelli” - Naples – Italy. He is the Head of Research in the Neuroimaging of Headache Disorders Laboratory of University of Campania
Prof. Dagny Holle Lee (MD, PhD) is a Neurologist and Head of the Wes tgerman Headache and Vertigo Center based in the Department of Neurology, University Hospital Essen, Germany